TickerFacts.

Sarepta Therapeutics, Inc. (SRPT): Share Repurchases

Annual figures by period end, from SEC filings.

$25.01M
Year ended 2025-12-31
2023-12-31: $02024-12-31: $02025-12-31: $25.01M$25.01M
2023-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$25.01Mn/a2026-03-02, From 2025-01-01
2024-12-31$0n/a2026-03-02, From 2024-01-01
2023-12-31$0n/a2026-03-02, From 2023-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Sarepta Therapeutics, Inc. (SRPT)2025-12-31$25.01Mn/a
Royalty Pharma plc (RPRX)2025-12-31$1.23B+434.5%
United Therapeutics Corp (UTHR)2025-12-31$1.00B0.0%
Alkermes plc. (ALKS)2024-12-31$200.28Mn/a
Indivior Pharmaceuticals, Inc. (INDV)2025-12-31$11.00M-93.6%
Jazz Pharmaceuticals plc (JAZZ)2025-12-31$125.02M-59.9%
Prestige Consumer Healthcare Inc. (PBH)2026-03-31$156.28M+203.4%
ANI Pharmaceuticals Inc (ANIP)2025-12-31$12.21M+11.4%
Collegium Pharmaceutical, Inc (COLL)2025-12-31$25.10M-58.2%

Compare SRPT, RPRX, UTHR, ALKS side by side · Screen every company in Pharmaceutical Preparations ↗